StarStarter for Anxiety, from Arcade Therapeutics, Awarded First APA Labs Digital Badge as Inaugural Recipient

StarStarter for Anxiety, from Arcade Therapeutics, Earns APA Labs Digital Badge as an Inaugural Recipient Featured in APA Labs’ Digital Solutions Library for clinicians, health systems, and users in search of safe, ethical, and evidence-based solutions FOR IMMEDIATE RELEASE New York — April 16, 2026 — As digital mental and behavioral health tools emerge in the market at an unprecedented

Read More

Arcade Therapeutics Makes Anxiety-Relief Game Available to YMCA of Montclair Members in Support of Mental Illness Awareness Week and World Mental Health Day

Arcade Therapeutics Makes Anxiety-Relief Game Available to YMCA of Montclair Members in Support of Mental Illness Awareness Week and World Mental Health Day Showcases Innovative New Paths to Engage Communities in Mental Well-Being FOR IMMEDIATE RELEASE Montclair, NJ, October 7, 2025 — Arcade Therapeutics announced today that YMCA of Montclair members will have access to its clinically validated, mobile casual

Read More

Arcade Therapeutics’ Game-Based Digital Therapeutic for Anxiety Shows Promising Results in Newly Published Clinical Study

Arcade Therapeutics’ Game-Based Digital Therapeutic for Anxiety Shows Promising Results in Newly Published Clinical Study Peer-Reviewed Study in the Journal of Anxiety Disorders Validates the Efficacy of Digital Therapeutics for Social Anxiety FOR IMMEDIATE RELEASE New York, NY (March 10, 2025) – Arcade Therapeutics, a pioneer in science-backed digital therapeutics, is excited to announce that the results of its latest

Read More

Arcade Therapeutics Named to the New York Digital Health 100 for 2025

Arcade Therapeutics Named to the New York Digital Health 100 for 2025 by Digital Health New York (DHNY) DH100 recognizes the most exciting and innovative digital health startups in New York FOR IMMEDIATE RELEASE New York, NY (February 10, 2025) – Arcade Therapeutics today announced that it has been named to the 2025 New York Digital Health 100 (DH100), a

Read More

Arcade Therapeutics Accepted to the February 2025 Cohort for the Innovations in Mental Health Immersion Programme

Arcade Therapeutics Accepted to the February 2025 Cohort for the Innovations in Mental Health Immersion Programme Company Joins Elite Cohort to Advance Digital Therapeutics on a Global Scale FOR IMMEDIATE RELEASE New York, NY (February 4, 2025) – Arcade Therapeutics has been accepted into the Innovations in Mental Health Immersion Programme. This prestigious 12-week program is dedicated to supporting startups

Read More

Arcade Therapeutics Named to the New York Digital Health 100

Arcade Therapeutics Named to the New York Digital Health 100 by Digital Health New York (DHNY) DH100 recognizes the most exciting and innovative digital health startups in New York FOR IMMEDIATE RELEASE New York, NY (February 6, 2024) – Arcade Therapeutics today announced that it has been named to the 2024 New York Digital Health 100 (DH100), a recognition that

Read More

Arcade Therapeutics and Kean University Offer Game-Based Digital Therapeutic to College Students with Social Anxiety

Arcade and Kean will launch a separate research study to investigate the impact of StarStarter Rx on student mental health. Arcade Therapeutics jointly announced a partnership with Kean University’s Counseling Center to offer students StarStarter Rx, a therapeutic mobile game designed to reduce social anxiety. Kean will offer free access to Arcade’s digital therapeutic as part of a broader initiative to expand its facilities and mental health resources. “Social anxiety can be debilitating to students’ lives by encouraging avoidant behavior through excessive rumination and worry. It can be the obstacle to joining an extracurricular activity, having fun with friends, or raising your hand in class…

Arcade Therapeutics and UT Austin Jointly Announce a $3.8M NIMH Grant to Fund Large Clinical Trial Testing the Efficacy of ABM-02, The First Game-Based Digital Therapeutic for Major Depressive Disorder

The R01 Grant from the National Institute of Health, consisting of $3.8M in funding to UT Austin’s Institute for Mental Health Research, was recently approved with a kickoff date of September 1st. Arcade Therapeutics and University of Texas Austin’s Institute for Mental Health Research jointly announced the closing of a $3.8M grant from the National Institute for Mental Health (NIMH) to support clinical investigation and validation of ABM-02 as a game-based treatment for Major Depressive Disorder (MDD)…

Clinical Trial of Arcade Therapeutics’ Flagship Therapeutic Mobile Game, StarStarter Rx, Shows Robust Reductions in Social Anxiety in Adults

Arcade Therapeutics (fka Wise Therapeutics) announced topline results of their StarStarter Rx Pilot Study, evaluating the efficacy and safety of their flagship digital therapeutic in adults 22-65 with Social Anxiety Disorder (SAD). The study achieved its predefined efficacy outcome for its primary endpoint, the Liebowitz Social Anxiety Scale (LSAS), as well as secondary and exploratory outcome measures such as the Beck Depression Inventory (BDI-II)…

Rx.Health and Arcade (FKA Wise Therapeutics) collaborate to provide game-based digital therapeutic to anxiety patients

(December 15, 2022, NEW YORK) Rx.Health, the leading evidence-based automated care coordination platform, has announced a partnership with Wise Therapeutics, a leading provider of game-based digital therapeutics for mental health. This partnership will enable Rx.Health’s health plan and health system users to deploy Wise’s mobile game to their patient populations as an integrated digital therapeutic for anxiety. Wise Therapeutics has developed

Read More